Search research articles
Contact Us
Filters
Showing results (231-240 of 259) with videos related to
Page
of 26
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
July 16, 2014
Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A
Romi Gupta, Yuying Dong, Peter D Solomon, et al.
Cancer Research Communications
|
February 27, 2025
A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence
Christopher C Jackson, Jia Jenny Liu, Howard Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2005
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, et al.
Iscience
|
August 18, 2025
AURKB and PI3K/AKT/mTOR pathways converge to regulate <i>TERT</i> expression
Grace Lim, Althea Bastian, Saskia Fung, et al.
Nature Communications
|
December 23, 2025
Large-scale drug sensitivity, gene dependency, and proteogenomic analyses of telomere maintenance mechanisms in cancer cells
Yangxiu Wu, Zhaoxiang Cai, Dale Cross, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 2, 2024
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression
Philip Kienzl, Abigail J Deloria, Monika Hunjadi, et al.
Genome Biology
|
March 29, 2023
CRISPR screens identify gene targets at breast cancer risk loci
Natasha K Tuano, Jonathan Beesley, Murray Manning, et al.
Nucleic Acids Research
|
May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumours
Michael Lee, Erdahl T Teber, Oliver Holmes, et al.
Plos Genetics
|
July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2026
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts
Adel T Aref, Mohashin Pathan, Rosemary Habib, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 259) with videos related to
Sort By:
Page
of 26
Proceedings of the National Academy of Sciences of the United States of America
|
July 16, 2014
Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A
Romi Gupta, Yuying Dong, Peter D Solomon, et al.
Cancer Research Communications
|
February 27, 2025
A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence
Christopher C Jackson, Jia Jenny Liu, Howard Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2005
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas
Jeremy D Henson, Jonathan A Hannay, Stanley W McCarthy, et al.
Iscience
|
August 18, 2025
AURKB and PI3K/AKT/mTOR pathways converge to regulate <i>TERT</i> expression
Grace Lim, Althea Bastian, Saskia Fung, et al.
Nature Communications
|
December 23, 2025
Large-scale drug sensitivity, gene dependency, and proteogenomic analyses of telomere maintenance mechanisms in cancer cells
Yangxiu Wu, Zhaoxiang Cai, Dale Cross, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 2, 2024
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression
Philip Kienzl, Abigail J Deloria, Monika Hunjadi, et al.
Genome Biology
|
March 29, 2023
CRISPR screens identify gene targets at breast cancer risk loci
Natasha K Tuano, Jonathan Beesley, Murray Manning, et al.
Nucleic Acids Research
|
May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumours
Michael Lee, Erdahl T Teber, Oliver Holmes, et al.
Plos Genetics
|
July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2026
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts
Adel T Aref, Mohashin Pathan, Rosemary Habib, et al.
Page
of 26